Newest first. 5.2k questions across 107 tags.
Conditions: survodutide · TRIUMPH-3. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
The specifics, since they change the answer: Changsha · Finland. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
For reference: oral semaglutide · 40 °C · fourteen days. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…
The specifics, since they change the answer: liraglutide · REDEFINE-1. I understand the observation; what I do not understand is the mechanism behind it. I have read…
The specifics, since they change the answer: QYB · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has…
The specifics, since they change the answer: MKM · Tianjin Finder Chemical. I am trying to choose between two options that are usually discussed as though only one…
Setup, so nobody has to ask: aggregation · a GLP-1 receptor agonist · room temperature. The empirical answer seems settled. The explanation does not. If the honest…
Stated plainly: WXT · Xi’an Mokemei Biotechnology. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
What I am working with: retatrutide · sampling plan. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
What I am working with: ALT · cagrilintide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the…
Stated plainly: TRIUMPH-3 · mazdutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do…
Details up front: 8 mg · 2.5 mg/mL. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is…
Numbers first: cagrilintide · five days. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method…
Details up front: cagrilintide · tirzepatide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible…
What I have: cagrilintide · 10 mg/mL. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked. Assume no…
Numbers first: cagrilintide · STEP 5. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
What I have: a GLP-1 receptor agonist · 0.9% sodium chloride. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody…
Numbers first: 124 kg · 1,000 kcal. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is…
What I have: PIONEER-1 · dulaglutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The case in front of me: headache · two · retatrutide. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of…
I am comparing three suppliers on documentation rather than on price. I have done this once and I suspect I got away with it rather than got it right. For context: I…
The particulars: date of analysis · HJ. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The particulars: Tianjin · South Africa. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
I have both a purity figure and a content figure, which is why the discrepancy is visible. An unexpected observation, and I would like a differential rather than…